Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of JTT-751 and Sevelamer in Hemodialysis Patients
jRCT2080221394Phase 3
- Sponsor
- Japan Tobacco
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ferric citrate in hyperphosphatemia (2 arms), sponsored by Japan Tobacco.
02
Drugs
ferric citrate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on jRCT2080221394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221394.